Merck & Co., Inc. (MRK)
NYSE$94.57
Market Cap
$238.89B
Sector
Healthcare
Industry
Drug Manufacturers—General
Rank in Sector
118 of 924
Rank in Industry
1 of 12
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
MRK Insider Trading Activity
MRK Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $1,577,500 | 2 | 40 |
Sells | $1,436,352 | 3 | 60 |
Related Transactions
| BAKER DOUGLAS M JR | director | 1 | $1.33M | 0 | $0 | $1.33M |
| THULIN INGE G | director | 1 | $250,000 | 0 | $0 | $250,000 |
| Downing Cristal N | Chief Comm. & Public Afrs Ofcr | 0 | $0 | 1 | $209,551 | $-209,551 |
| Williams David Michael | EVP,Chief Info&Digital Officer | 0 | $0 | 1 | $512,057 | $-512,057 |
| Oosthuizen Johannes Jacobus | President, U.S. Market | 0 | $0 | 1 | $714,745 | $-714,745 |
About Merck & Co., Inc.
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions …
Insider Activity of Merck & Co., Inc.
Over the last 12 months, insiders at Merck & Co., Inc. have bought $1.58M and sold $1.44M worth of Merck & Co., Inc. stock.
On average, over the past 5 years, insiders at Merck & Co., Inc. have bought $540,612 and sold $112.71M worth of stock each year.
Highest buying activity among insiders over the last 12 months: BAKER DOUGLAS M JR (director) — $1.33M. THULIN INGE G (director) — $250,000.
The last purchase of 2,833 shares for transaction amount of $250,000 was made by THULIN INGE G (director) on 2025‑02‑06.
List of Insider Buy and Sell Transactions, Merck & Co., Inc.
| 2025-02-19 | Sale | Oosthuizen Johannes Jacobus | President, U.S. Market | 8,500 0.0003% | $84.09 | $714,745 | +11.07% | |
| 2025-02-13 | Sale | Williams David Michael | EVP,Chief Info&Digital Officer | 6,000 0.0002% | $85.34 | $512,057 | +9.47% | |
| 2025-02-06 | Sale | Downing Cristal N | Chief Comm. & Public Afrs Ofcr | 2,361 <0.0001% | $88.76 | $209,551 | +3.66% | |
| 2025-02-06 | THULIN INGE G | director | 2,832.86 0.0001% | $88.25 | $250,000 | +3.66% | ||
| 2025-02-05 | BAKER DOUGLAS M JR | director | 15,000 0.0006% | $88.50 | $1.33M | +1.43% | ||
| 2024-02-14 | Sale | Davis Robert M | Chairman, CEO & President | 85,021 0.0034% | $125.40 | $10.66M | -6.22% | |
| 2024-02-14 | Sale | Litchfield Caroline | EVP & CFO | 38,291 0.0015% | $125.50 | $4.81M | -6.22% | |
| 2024-02-13 | Sale | Davis Robert M | Chairman, CEO & President | 150,000 0.0059% | $125.85 | $18.88M | -5.90% | |
| 2024-02-13 | Sale | Romanelli Joseph | President, Human Health Int?l | 1,000 <0.0001% | $124.89 | $124,888 | -5.90% | |
| 2024-02-09 | Sale | Li Dean Y | Executive VP & President, MRL | 14,702 0.0006% | $125.50 | $1.85M | -5.22% | |
| 2024-02-07 | Sale | Williams David Michael | EVP,Chief Info&Digital Officer | 1,451 <0.0001% | $127.57 | $185,108 | -6.41% | |
| 2024-02-02 | Sale | Zachary Jennifer | EVP, General Counsel | 49,499 0.002% | $126.97 | $6.28M | -5.02% | |
| 2024-02-02 | Sale | MIZELL STEVEN | EVP, Chief HR Officer | 50,694 0.0021% | $126.65 | $6.42M | -5.02% | |
| 2024-02-02 | Sale | Oosthuizen Johannes Jacobus | President, U.S. Market | 18,959 0.0008% | $127.17 | $2.41M | -5.02% | |
| 2023-11-09 | Sale | Oosthuizen Johannes Jacobus | President, U.S. Market | 2,081 <0.0001% | $102.38 | $213,061 | +18.96% | |
| 2023-11-08 | Sale | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | 43,823 0.0017% | $105.03 | $4.6M | +16.61% | |
| 2023-08-14 | Sale | MIZELL STEVEN | EVP, Chief HR Officer | 4,250 0.0002% | $109.01 | $463,293 | +12.48% | |
| 2023-08-03 | Sale | MIZELL STEVEN | EVP, Chief HR Officer | 4,500 0.0002% | $105.49 | $474,701 | +15.88% | |
| 2023-08-02 | Sale | Romanelli Joseph | President, Human Health Int?l | 89 <0.0001% | $107.37 | $9,556 | +15.90% | |
| 2023-05-04 | Sale | Karachun Rita A | Sr. VP Fince-Global Controller | 15,875 0.0006% | $117.53 | $1.87M | -5.68% |
Total: 238
*Gray background shows transactions not older than one year
Insider Historical Profitability
4.3%
| BAKER DOUGLAS M JR | director | 16000 0.0006% | $1.51M | 1 | 0 | |
| THULIN INGE G | director | 2933 0.0001% | $277,360.66 | 1 | 0 | |
| HASSAN FRED | Chairman and CEO | 720800 0.0285% | $68.17M | 2 | 0 | <0.0001% |
| FRAZIER KENNETH C | Executive Chair | 700653 0.0277% | $66.26M | 1 | 40 | +21.77% |
| SABATINO THOMAS J JR | Executive Vice President | 309535 0.0123% | $29.27M | 1 | 0 |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$364,217,072 | 28 | 9.11% | $20.41B | |
$6,077,160 | 24 | 3.21% | $391.98B | |
$1,922,773,492 | 23 | 18.03% | $771.17B | |
$28,542,809 | 19 | 26.40% | $373.85B | |
$23,029,445 | 18 | 9.34% | $119.75B |
MRK Institutional Investors: Active Positions
| Increased Positions | 1,687 | +42.39% | 146M | +7.48% |
| Decreased Positions | 1,825 | -45.85% | 110M | -5.64% |
| New Positions | 346 | New | 32M | New |
| Sold Out Positions | 218 | Sold Out | 8M | Sold Out |
| Total Postitions | 3,842 | -3.47% | 2B | +1.84% |
MRK Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $23.16M | 9.94% | 251.1M | +1M | +0.52% | 2024-12-31 |
| Blackrock, Inc. | $20.49M | 8.79% | 222.08M | +10M | +4.73% | 2024-12-31 |
| State Street Corp | $11.15M | 4.79% | 120.91M | +2M | +1.58% | 2024-12-31 |
| Wellington Management Group Llp | $7.45M | 3.2% | 80.74M | +5M | +6.51% | 2024-12-31 |
| Geode Capital Management, Llc | $5.64M | 2.42% | 61.18M | +2M | +3.43% | 2024-12-31 |
| Morgan Stanley | $4.08M | 1.75% | 44.18M | -208,123 | -0.47% | 2024-12-31 |
| Fmr Llc | $3.45M | 1.48% | 37.36M | -12M | -24.84% | 2024-12-31 |
| Bank Of America Corp /De/ | $3.36M | 1.44% | 36.44M | -2M | -6.23% | 2024-12-31 |
| Norges Bank | $3.23M | 1.39% | 34.98M | +1M | +3.47% | 2024-12-31 |
| Northern Trust Corp | $2.89M | 1.24% | 31.38M | +5M | +16.79% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.